Association of vitamin D and magnesium with insulin sensitivity and their influence on glycemic control.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analytic data synthesis
PubMed 36684386 · doi:10.4239/wjd.v14.i1.26
What was done
This was a narrative review summarizing literature on the roles of vitamin D and magnesium in insulin sensitivity, pancreatic beta-cell function, and glycemic control in patients with diabetes.
What was found
No quantitative data, effect sizes, or statistical metrics are reported in the abstract. The authors state that increasing vitamin D levels alone does not reliably improve insulin function or glycemic control, but magnesium is required for vitamin D transport and activation. The abstract notes that patients with good glycemic control have higher magnesium levels and that combined supplementation with vitamin D and magnesium improves glycemic control in patients with diabetes.
Why it matters
Highlighting the biochemical dependence of vitamin D activation on magnesium offers a mechanistic hypothesis for why standalone vitamin D supplementation trials have shown inconsistent effects on glycemic control.
Limits
As a narrative review, it lacks a systematic literature search, meta-analytic pooling, study count, and sample size details in the abstract. The abstract provides no primary data or numerical findings to evaluate the strength of the reported associations.
Cited by
- supports Magnesium is a required cofactor for the enzymes that convert vitamin D3 into its active steroid hormone form.